Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(2):176; doi:10.1093/jnci/djk022
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Bria, E.
Right arrow Articles by Giannarelli, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bria, E.
Right arrow Articles by Giannarelli, D.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Re: Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis

Emilio Bria, Paolo Carlini, Francesco Cognetti, Edmondo Terzoli, Diana Giannarelli

Affiliations of authors: Departments of Medical Oncology (EB, PC, FC, ET) and Biostatistics (DG), Regina Elena National Cancer Institute, Rome, Italy

Correspondence to: Emilio Bria, MD, Department of Medical Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy (e-mail: emiliobria@yahoo.it).

The first 10% of the full text of this article appears below.

The recent article in the Journal by Mauri et al. (1) of a meta-analysis investigating the impact of aromatase inhibitors on survival provides an opportunity to explore some relevant issues in summarizing data from randomized trials. A synthetic approach, such . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

Response: Re: Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis
John P. A. Ioannidis, Davide Mauri, Nikolaos P. Polyzos, and Nicholas Pavlidis
J Natl Cancer Inst 2007 99: 176-177. [Extract] [Full Text] [PDF]